One In, One Out: Mirum Seeks New EU Indication For Maralixibat, Withdraws Another

Kyowa Kirin And Sanofi Want CHMP To Re-Examine Earlier Opinion About Their Products

 
• By Vibha Sharma
  
Small colorful alarm clocks without hands pattern minimal creative no time concept.
Companies Can Withdraw Their Marketing Applications At Any Stage Of The EMA Review • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards